preliminary data from a prospective randomized study of the use of a short course of adrenocorticosteroids in 73 children with itp demonstrates a significant advantage of moderate dose ( 60 mg/m2/day p.o . x 21 days ) prednisolone therapy in decreasing the duration of severe thrombocytopenia in most patients .
C0032950
therapy
C0040034
thrombocytopenia